Telo Genomics Corp. (TDSGF)
OTCMKTS · Delayed Price · Currency is USD
0.0315
-0.0002 (-0.51%)
Feb 12, 2026, 9:30 AM EST
Telo Genomics Market Cap
Telo Genomics has a market cap or net worth of $3.68 million as of February 12, 2026. Its market cap has decreased by -48.36% in one year.
Market Cap
3.68M
Enterprise Value
3.33M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since September 13, 2016, Telo Genomics's market cap has decreased from 17.64M to 3.68M, a decrease of -79.12%. That is a compound annual growth rate of -15.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 3.68M | 0.58% |
| Dec 31, 2025 | 3.66M | -59.47% |
| Dec 30, 2024 | 9.04M | -16.33% |
| Dec 29, 2023 | 10.80M | -30.72% |
| Dec 30, 2022 | 15.59M | -19.04% |
| Dec 31, 2021 | 19.25M | 88.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Sep 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioqual | 33.55M |
| Longduoduo Company | 17.81M |
| Aspira Women's Health | 15.96M |
| Psychemedics | 10.16M |
| Hypha Labs | 5.13M |
| Stella Diagnostics | 4.67M |
| Centogene | 3.16M |
| InVitro International | 1.67M |